Calyxo, Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Delaware
- Sector
- Healthtech
- Headquarters
- Pleasanton, CA
- Street
- 4473 Willow Road, Suite 100
- Zip
- 94588
Offering
- Total offering
- $40.1M
- Amount sold
- $40.1M
- First sale
- Apr 1, 2026
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 12
How this filing compares
Ranked #4 of 63 Healthtech filings in April 2026 by offering amount.
Median Healthtech filing in April 2026: $3.4M. This offering is 12.0× the median.
Other California filings this week: Blue Opportunity Fund, LP, CHECKPOINT CAPITAL (OFFSHORE) FUND LP, CHECKPOINT CAPITAL (ONSHORE) FUND LP, CompleteFarmer Technologies, Inc., ExchangeRight Income Fund Operating Partnership, LP
Leadership
Jee Shin — Executive Officer (also: Director)
Douglas Hughes — Executive Officer (also: Director)
Ryan Drant — Director
Dave Amerson — Director
Joe Catanese — Executive Officer (also: Director)
Chris Buchko — Executive Officer
Jacob Garfield — Director
Dana G. Mead — Director
Filing details
Calyxo, Inc. filed a Form D with the SEC on April 16, 2026.